Skip to main content
. Author manuscript; available in PMC: 2015 Aug 8.
Published in final edited form as: Transpl Infect Dis. 2015 Jun 26;17(4):536–543. doi: 10.1111/tid.12402

Table 1.

Demographic data and transplant characteristics

Group 1
(n = 32)
Group 2
(n = 36)
P-value

Age (yrs; mean ±SD) 56.7 ± 10.9 51.5 ± 11.1 0.056

Recipient male gender 24 (75.0%) 25 (69.4%) 0.787

Race
   Asian 2 (6.3%) 1 (2.8%) 0.598
   Black 4 (12.5%) 12 (33.3%) 0.051
   Hispanic 2 (6.3%) 3 (8.3%) 1.000
   Caucasian 23 (71.8%) 19 (52.8%) 1.000
   Other 1 (3.1%) 1 (2.8%) 0.136

Previous transplant 5 (15.6%) 10 (27.8%) 0.257

Diabetes mellitus 15 (46.9%) 6 (16.7%) 0.009

Living donor 17 (53.1%) 18 (50.0%) 0.813

ECD* 8 (25.0%) 9 (25.0%) 1.000

Donor age (yrs) 47.5 + 15.6 47.2 + 15.1 0.937

Donor male gender 16 (15%) 15 (41.7%) 0.626

Donor race 0.618
   Black 1 (3.1%) 3 (8.3%)
   Non-Black 31 (96.9%) 33 (91.7%)

Cold ischemic time (minutes) 491.8 ± 538.4 496.5 ± 499.6 0.971

Warm ischemic time (minutes) 35.2 ± 11.2 36.1 ± 8.5 0.713

Number of HLA mismatches 3.7 ± 2.1 4.1 ± 1.8 0.401

DGF** 7 (21.9%) 9 (25.0%) 0.780
*

Expanded criteria donor (ECD): any deceased donor > age 60 yrs or a donor > 50 yrs with 2 of the following: a history of hypertension; a terminal serum Cr >1.5 mg/dL; or death from stroke.

**

Delayed Graft Function (DGF): the need for hemodialysis within the first 7 days post renal transplant.

Yrs, years; SD, standard deviation; HLA. human leukocyte antigen; Cr, creatinine.